Targeted inhibition of p38α MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy
- 1 November 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 337 (3), 928-935
- https://doi.org/10.1016/j.bbrc.2005.09.135
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Arachidonic Acid Released by Phospholipase A2 Activation Triggers Ca2+-dependent Apoptosis through the Mitochondrial PathwayPublished by Elsevier ,2004
- Up-regulation of Cyclooxygenase-2 and Apoptosis Resistance by p38 MAPK in Hypericin-mediated Photodynamic Therapy of Human Cancer CellsJournal of Biological Chemistry, 2003
- Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapyThe FASEB Journal, 2003
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Phospolipase A2 and apoptosisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
- Many actions of cyclooxygenase‐2 in cellular dynamics and in cancerJournal of Cellular Physiology, 2002
- Hypericin in cancer treatment: more light on the wayThe International Journal of Biochemistry & Cell Biology, 2001
- Cyclooxygenases: Structural, Cellular, and Molecular BiologyAnnual Review of Biochemistry, 2000
- The Activation of the c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase Signaling Pathways Protects HeLa Cells from Apoptosis Following Photodynamic Therapy with HypericinJournal of Biological Chemistry, 1999
- Photodynamic TherapyJNCI Journal of the National Cancer Institute, 1998